The peripheral immune response and lung cancer prognosis

Attempts to refine and improve outcome predictions using tumor gene expression have been recently reported. We show that peripheral blood mononuclear cell (PBMC)-associated gene signatures can predict outcome in non-small cell lung carcinoma patients independent of demographic data or TNM staging, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Showe, Michael K., Kossenkov, Andrew V., Showe, Louise C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518521/
https://www.ncbi.nlm.nih.gov/pubmed/23243612
http://dx.doi.org/10.4161/onci.21096
_version_ 1782252568323293184
author Showe, Michael K.
Kossenkov, Andrew V.
Showe, Louise C.
author_facet Showe, Michael K.
Kossenkov, Andrew V.
Showe, Louise C.
author_sort Showe, Michael K.
collection PubMed
description Attempts to refine and improve outcome predictions using tumor gene expression have been recently reported. We show that peripheral blood mononuclear cell (PBMC)-associated gene signatures can predict outcome in non-small cell lung carcinoma patients independent of demographic data or TNM staging, and that this information may persist after tumor resection.
format Online
Article
Text
id pubmed-3518521
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-35185212012-12-14 The peripheral immune response and lung cancer prognosis Showe, Michael K. Kossenkov, Andrew V. Showe, Louise C. Oncoimmunology Author's View Attempts to refine and improve outcome predictions using tumor gene expression have been recently reported. We show that peripheral blood mononuclear cell (PBMC)-associated gene signatures can predict outcome in non-small cell lung carcinoma patients independent of demographic data or TNM staging, and that this information may persist after tumor resection. Landes Bioscience 2012-11-01 /pmc/articles/PMC3518521/ /pubmed/23243612 http://dx.doi.org/10.4161/onci.21096 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Showe, Michael K.
Kossenkov, Andrew V.
Showe, Louise C.
The peripheral immune response and lung cancer prognosis
title The peripheral immune response and lung cancer prognosis
title_full The peripheral immune response and lung cancer prognosis
title_fullStr The peripheral immune response and lung cancer prognosis
title_full_unstemmed The peripheral immune response and lung cancer prognosis
title_short The peripheral immune response and lung cancer prognosis
title_sort peripheral immune response and lung cancer prognosis
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518521/
https://www.ncbi.nlm.nih.gov/pubmed/23243612
http://dx.doi.org/10.4161/onci.21096
work_keys_str_mv AT showemichaelk theperipheralimmuneresponseandlungcancerprognosis
AT kossenkovandrewv theperipheralimmuneresponseandlungcancerprognosis
AT showelouisec theperipheralimmuneresponseandlungcancerprognosis
AT showemichaelk peripheralimmuneresponseandlungcancerprognosis
AT kossenkovandrewv peripheralimmuneresponseandlungcancerprognosis
AT showelouisec peripheralimmuneresponseandlungcancerprognosis

Ejemplares similares